For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Amylyx Pharmaceuticals Inc’s stock clocked out at $5.15, down -3.20% from its previous closing price of $5.32. In other words, the price has decreased by -$3.20 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
To gain a deeper understanding of AMLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.67 and its Current Ratio is at 6.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 18, 2024, Robert W. Baird Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $3 to $11.
BofA Securities Upgraded its Neutral to Buy on October 23, 2024, whereas the target price for the stock was revised from $4.20 to $10.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.25 while its Price-to-Book (P/B) ratio in mrq is 2.15.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 32.52%, while the 200-Day Moving Average is calculated to be 39.67%.
Shares Statistics:
A total of 68.63M shares are outstanding, with a floating share count of 66.62M. Insiders hold about 25.22% of the company’s shares, while institutions hold 56.35% stake in the company.
